440 Participants Needed

Pain Communication Toolkit for Caregivers of Alzheimer's Patients

(PICT Trial)

LB
LM
LS
Overseen ByLisa Sacerio
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techniques. It will recruit participants from programs of all-inclusive care for the elderly (PACE) and partnering health care clinics. The investigators hypothesize that PICT will help caregivers to recognize and communicate about pain in their care recipients.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the Pain Identification and Communication Toolkit (PICT) treatment for caregivers of Alzheimer's patients?

The Pain Identification and Communication Toolkit (PICT) has shown promise in a pilot trial by training caregivers to better recognize and communicate about pain in dementia patients, which is often underdetected and undermanaged. This suggests that PICT could help improve pain management by empowering caregivers with the skills needed to identify and report pain effectively.12345

Is the Pain Communication Toolkit safe for use in humans?

The Pain Identification and Communication Toolkit (PICT) has been evaluated in a pilot trial for caregivers of people with dementia, focusing on training for pain assessment and communication. The study did not report any safety concerns, suggesting it is generally safe for use in humans.12467

How is the Pain Communication Toolkit treatment different from other treatments for Alzheimer's patients?

The Pain Communication Toolkit is unique because it focuses on training caregivers to better observe and communicate about pain in Alzheimer's patients, rather than directly treating the pain itself. This approach empowers caregivers to play a crucial role in pain management by improving their ability to recognize and report pain symptoms, which is often challenging in patients who cannot communicate effectively.148910

Research Team

CA

Catherine A Riffin, PhD

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for caregivers over 21 years old who speak English, are cognitively intact, and provide weekly care to someone with dementia or cognitive impairment and chronic pain enrolled in a PACE program. The person with dementia must not be in hospice or have a terminal illness with less than 6 months life expectancy.

Inclusion Criteria

I have been diagnosed with pain.
I visit the person I care for at least once a week.
CAREGIVER PARTICIPANTS: Provides care to a PACE participant
See 12 more

Exclusion Criteria

PATIENT PARTICIPANTS: Unresponsive to environment
I visit the person I care for less than once a week.
CAREGIVER PARTICIPANTS: Does not provide care to a person with dementia or cognitive impairment who also has a pain diagnosis
See 13 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Pain Identification and Communication Toolkit (PICT) intervention, consisting of 4 weekly telephone sessions (30-60 minutes each) delivered by a trained interventionist.

4 weeks
4 visits (telephone)

Follow-up

Participants are monitored for changes in pain management and caregiver self-efficacy at 1, 3, and 6 months post-treatment.

6 months
3 visits (assessment at 1, 3, and 6 months)

Treatment Details

Interventions

  • Pain Identification and Communication Toolkit
Trial Overview The study tests the Pain Identification and Communication Toolkit (PICT), designed to help caregivers of people with Alzheimer's disease recognize and communicate about their care recipient's pain through training and coaching.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Pain Identification and Communication ToolkitExperimental Treatment1 Intervention
The Pain Identification and Communication Toolkit (PICT) components include: a) training using an observational assessment tool to detect pain in persons with Alzheimer's disease and related dementias (ADRD), b) coaching and feedback by a trained interventionist in effective strategies for communicating with providers about pain, c) future planning for what steps to take when a pain symptom is detected, and d) updating the caregiver's skill set through routine practice and homework exercises. A trained interventionist will deliver the PICT intervention following a manualized protocol to the caregiver participants. Patient participants will not receive any intervention.
Group II: Attention ControlPlacebo Group1 Intervention
The Attention Control (AC) condition, also known as the Health Promotion Program (HPP), focuses on caregiver health promotion topics, such as nutrition, exercise, and sleep. A trained interventionist will provide education on these topics using scripted material, use active listening and open questioning techniques, and provide the HPP participants with worksheets (e.g., meal plans) to complete between sessions to mirror the homework activities in the PICT condition for the caregiver participants. Patient participants will not receive any intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

Accurate pain management in patients with advanced dementia and Alzheimer's Disease requires individualized and ongoing pain assessment, as self-reports may not be possible due to communication difficulties.
The article introduces a scientifically validated pain assessment tool specifically designed for non-verbal patients, emphasizing the importance of recognizing the patient's authority on their pain experience.
A pain assessment tool for people with advanced Alzheimer's and other progressive dementias.Lane, P., Kuntupis, M., MacDonald, S., et al.[2019]
The study evaluated a multi-dimensional tool for assessing pain in cognitively impaired adults, revealing that certain pain indicators were more frequently observed and documented, particularly during morning shifts.
Nurses' compliance in recording pain observations was inconsistent, highlighting the need for better training and support to enhance pain assessment practices, which should combine physiological and behavioral indicators based on clinical judgment.
Pain assessment and cognitive impairment: part 2.Davies, E., Male, M., Reimer, V., et al.[2019]
The Pain Assessment in Advanced Dementia (PAINAD) tool was developed and validated for assessing pain in individuals with advanced dementia who cannot communicate their pain, showing good reliability and validity in a study involving 19 residents and expert clinicians.
PAINAD effectively detected changes in pain levels before and after analgesic medication was administered, indicating its potential utility in clinical settings for improving pain management in noncommunicative patients.
Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale.Warden, V., Hurley, AC., Volicer, L.[2022]

References

A pain assessment tool for people with advanced Alzheimer's and other progressive dementias. [2019]
Pain assessment and cognitive impairment: part 2. [2019]
Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. [2022]
Establishing the Feasibility and Acceptability of a Caregiver Targeted Intervention to Improve Pain Assessment Among Persons With Dementia. [2023]
Development and evaluation of the Pain Assessment in the Communicatively Impaired (PACI) tool: part I. [2018]
Using Pictures to Assess Pain Location in Children. [2019]
Algoplus® Scale in Older Patients with Dementia: A Reliable Real-World Pain Assessment Tool. [2019]
Caregiver-provider communication about pain in persons with dementia. [2023]
How do patients with Alzheimer's disease imagine their pain? [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Pain assessment as intervention: a study of older adults with severe dementia. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security